Polypharmakos and CABI to develop new antimicrobial products from CABI Culture Collection
Polypharmakos Limited, a spin-out company from the UK’s Royal Botanic Gardens Kew and University of Cambridge, and international not-for-profit organisation CABI have signed a research collaboration and licensing agreement to develop novel products from CABI’s Culture Collection.
CABI’s Culture Collection consists of 30,000 strains of optimally preserved fungi and bacteria isolated from diverse ecosystems from around the world – a reflection of CABI’s work and mission to improve lives by solving problems in agriculture and the environment.
Display your AMR Technology, Product and Service
Suppliers and Users of Technologies, Products and Services benefit from CAPI.
CAPI (Continuous AMR Partnering Initiative) unites Suppliers and Users worldwide with the aim to add to the curbing of AMR.